- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Statutory Instruments
National Health Service, England
Made
23rd February 2011
Laid before Parliament
28th February 2011
Coming into force
1st April 2011
The Secretary of State for Health makes the following Regulations in exercise of the powers conferred by sections 7(1), 8, 272(7) and (8) and 273(1) and (4) of the National Health Service Act 2006(1).
1.—(1) These Regulations may be cited as the National Health Service (Functions of Strategic Health Authorities and Primary Care Trusts and Administration Arrangements) (England) (Amendment) Regulations 2011 and shall come into force on 1st April 2011.
(2) In these Regulations, “the principal Regulations” means the National Health Service (Functions of Strategic Health Authorities and Primary Care Trusts and Administration Arrangements) (England) Regulations 2002(2).
2. For Schedule 5 to the principal Regulations (Secretary of State’s functions under section 3(1) of the National Health Service Act 2006 exercisable by Strategic Health Authorities for the purpose of securing the provision of services: specified services)(3) substitute the following Schedule—
Regulation 3(2A)
| 1 | Alström syndrome service |
| 2 | Ataxia telangiectasia service for children |
| 3 | Autoimmune paediatric gut syndromes service |
| 4 | Autologous intestinal reconstruction in adult patients |
| 5 | Bardet-Biedl syndrome service |
| 6 | Barth syndrome service |
| 7 | Bladder exstrophy service |
| 8 | Choriocarcinoma service |
| 9 | Chronic pulmonary aspergillosis service |
| 10 | Complex childhood osteogenesis imperfecta |
| 11 | Complex Ehlers Danlos syndrome service |
| 12 | Complex neurofibromatosis type 1 service |
| 13 | Complex tracheal disease service |
| 14 | Congenital hyperinsulinism service |
| 15 | Craniofacial service |
| 16 | Cryopyrin associated periodic syndrome service |
| 17 | Diagnostic service for amyloidosis |
| 18 | Diagnostic service for primary ciliary dyskinesia |
| 19 | Diagnostic service for rare neuromuscular disorders service |
| 20 | Encapsulating sclerosing peritonitis surgical service |
| 21 | Epidermolysis bullosa service |
| 22 | Extra corporeal membrane oxygenation service for adults |
| 23 | Extra corporeal membrane oxygenation service for neonates, infants and children with respiratory failure |
| 24 | Gender identity development service for children and adolescents |
| 25 | Heart and lung transplantation service (including bridge to transplant using mechanical circulatory support) |
| 26 | Insulin-resistant diabetes service |
| 27 | Islet transplantation service |
| 28 | Liver transplantation service |
| 29 | Lymphangioleiomyomatosis |
| 30 | Lysosomal storage disorder service |
| 31 | McArdle’s disease service |
| 32 | Mental health service for deaf children and adolescents |
| 33 | Neurofibromatosis type 2 service |
| 34 | Neuromyelitis optica service |
| 35 | Ocular oncology service |
| 36 | Ophthalmic pathology service |
| 37 | Osteo-odonto-keratoprosthesis service for corneal blindness |
| 38 | Pancreas transplantation service |
| 39 | Paroxysmal nocturnal haemoglobinuria service |
| 40 | Paediatric intestinal pseudo-obstructive disorders |
| 41 | Primary malignant bone tumours service |
| 42 | Proton beam therapy service |
| 43 | Pseudomyxoma peritonei service |
| 44 | Pulmonary hypertension service for children |
| 45 | Pulmonary thromboendarterectomy service |
| 46 | Rare mitochondrial disorders service |
| 47 | Reconstructive surgery service for adolescents for congenital malformation of the female genital tract |
| 48 | Retinoblastoma service |
| 49 | Secure forensic mental health service for young people |
| 50 | Severe combined immunodeficiency and related disorders service |
| 51 | Severe intestinal failure service |
| 52 | Severe obsessive compulsive disorder and body dysmorphic disorder service |
| 53 | Small bowel transplantation service |
| 54 | Specialist paediatric liver disease service |
| 55 | Stem cell transplantation service for juvenile idiopathic arthritis and related connective tissue disorders |
| 56 | Stickler syndrome diagnostic service |
| 57 | Vein of Galen malformation service |
| 58 | Veterans’ post-traumatic stress disorder programme |
| 59 | Wolfram syndrome |
| 60 | Xeroderma pigmentosum service.” |
Signed by authority of the Secretary of State for Health.
Earl Howe
Parliamentary Under-Secretary of State,
Department of Health
23rd February 2011
(This note is not part of the Regulations)
These Regulations, which apply in relation to England, further amend the National Health Service (Functions of Strategic Health Authorities and Primary Care Trusts and Administration Arrangements) (England) Regulations 2002 (“the principal Regulations”).
Regulation 2 substitutes a new Schedule 5 to the principal Regulations. Schedule 5 lists the specialised services whose provision is to be secured in England by Strategic Health Authorities, rather than Primary Care Trusts. The revised list adds new services that Strategic Health Authorities may commission.
The new services are—
Autologous intestinal reconstruction in adult patients (item 4)
Complex childhood osteogenesis imperfecta (item 10)
Insulin-resistant diabetes service (item 26)
Lymphangioleiomyomatosis (item 29)
Paediatric intestinal pseudo-obstructive disorders (item 40)
Stickler syndrome diagnostic service (item 56)
Veterans’ post-traumatic stress disorder programme (item 58)
Wolfram syndrome (item 59).
A full impact assessment has not been produced for this instrument as no impact on the private or voluntary sectors is foreseen.
2006 c.41. By virtue of section 271 of the Act the powers of the Secretary of State exercised in these provisions are exercisable only in relation to England. See section 275(1) for the definition of “Regulations”.
S.I. 2002/2375; relevant amending instruments are S.I. 2007/559, 2008/224, 2009/ 112 and 2010/405.
Schedule 5 was added to the principal Regulations by S.I. 2007/559, regulation 6, and was amended by S.I. 2008/224, 2009/ 112 and 2010/405. See also regulation 3(2A) of the principal Regulations, which refers to Schedule 5 and was added by S.I. 2007/559, regulation 3(3).
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: